Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AMLX
#1979
Amylyx Pharmaceuticals, Inc. - Common Stock
18.3
2
USD
+0.05%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+5.23%
Monthly Change
+23.87%
6 month change
+29.65%
Year Change
+117.84%
Previous Close
17.4
1
Open
18.2
8
Low
18.2
6
High
18.3
9
Volume
403
Markets
US Stock Market
Healthcare
Biotechnology
AMLX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
66.72 M
67.78 M
88.6 M
110.54 M
111.19 M
Valuation ratios
Enterprise value
2.34 B
844.5 M
257.53 M
1.11 B
1.76 B
Price to earnings ratio
-10.61
21.39
-0.85
-7.9
-12.09
Price to sales ratio
94.68
2.75
2.95
—
—
Price to cash flow ratio
11.7
87.91
1.54
-9.26
-14.46
Price to book ratio
6.18
2.42
1.56
3.74
1.61
Enterprise value to EBITDA ratio
-11.52
28.2
-0.8
-7
-10.78
Profitability ratios
Return on assets %
-0.51
0.1
-1.56
-0.44
-0.14
Return on equity %
-0.58
0.11
-1.83
-0.47
-0.15
Return on invested capital %
-2 399.24
282.41
-3 491.15
-5 993.93
—
Gross margin %
86.54
93.32
93.19
—
—
Operating margin %
-905.72
10.19
-360.22
—
—
EBITDA margin %
-912.78
7.87
-370.47
—
—
Net margin %
-892.38
12.94
-345.36
—
—
Liquidity ratios
Quick ratio
7.99
5.2
6.67
—
—
Current ratio
8.2
5.66
6.67
14.27
17.85
Inventory turnover
0.31
1.06
0.31
—
—
Asset turnover
0.06
0.84
0.25
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-3.07
0.17
-2.46
-1.3
-1.24
EBIT per share
-3.44
0.55
-4.62
-1.62
-1.65
EBITDA per share
-3.47
0.43
-4.75
-1.67
-1.69
Total debt per share
—
—
—
—
—
Cash per share
5.93
5.31
2.59
3.35
2.53
Net current asset value per share
6.53
6.64
2.78
3.42
2.58
Tangible book value per share
5.82
6.19
2.42
3.23
2.47
Working capital per share
5.74
5.47
2.36
3.18
2.43
Book value per share
5.82
6.19
2.42
3.23
2.47
News
H.C. Wainwright raises Amylyx stock price target to $34 on trial confidence
Amylyx shares fall over 3% on trial uncertainty despite earnings beat
Stifel initiates Amylyx stock with buy rating on drug potential
Amylyx set to report earnings as avexitide trial nears finish
Amylyx stock price target raised to $28 from $20 at H.C. Wainwright
Amylyx Pharmaceuticals: Back From The Dead (NASDAQ:AMLX)
Amylyx Pharmaceuticals stock hits 52-week high at $16.96
Amylyx pharma co-CEO Cohen sells $1.87m in shares
Amylyx pharma co-CEO Klee sells $1.88 million in AMLX stock
Mizuho reiterates Outperform rating on Amylyx stock, cites GLP-1 program
Amylyx Pharma director Firestone buys $100k in AMLX stock
TD Cowen analyst highlights 10+ potential biotech catalysts for 2026